Figures & data
Figure 1. AAT level distribution according to genotype (PI*MM, PI*MS and PI*MZ) in those with (dashed lines) and without (solid lines) the presence of inflammation, defined as CRP ≥5 mg/L and <5 mg/dL, respectively.
Reproduced from Sanders, Ponte and Kueppers. COPD 2018;15:10-16 [Citation6]
![Figure 1. AAT level distribution according to genotype (PI*MM, PI*MS and PI*MZ) in those with (dashed lines) and without (solid lines) the presence of inflammation, defined as CRP ≥5 mg/L and <5 mg/dL, respectively.Reproduced from Sanders, Ponte and Kueppers. COPD 2018;15:10-16 [Citation6]](/cms/asset/a56bf7cb-78d3-4cc6-8e4d-6416b357c83d/icop_a_1812055_f0001_c.jpg)
Figure 2. Changes in AAT levels of serum following the intravenous injection of 0.2 ml typhoid-paratyphoid vaccine (arrow) in the genetically different individuals. Homozygotes for common gene: solid line, heterozygotes for AATD gene: dashed line, homozygotes for deficiency gene: dotted line. At the right: standard error of the method.
Reproduced from Kueppers, Humangenetik 1968;6:207-14 [Citation14]
![Figure 2. Changes in AAT levels of serum following the intravenous injection of 0.2 ml typhoid-paratyphoid vaccine (arrow) in the genetically different individuals. Homozygotes for common gene: solid line, heterozygotes for AATD gene: dashed line, homozygotes for deficiency gene: dotted line. At the right: standard error of the method.Reproduced from Kueppers, Humangenetik 1968;6:207-14 [Citation14]](/cms/asset/356de21c-f8d0-4f94-bce6-fc07456e023e/icop_a_1812055_f0002_b.jpg)
Table 1. Comparison of observed and adjusted AAT levels calculated using the algorithm in the Sanders et al. cohort [Citation6].